Erratum: “Impact of a Biomarker-Based Strategy on Oncology Drug Development: A Meta-Analysis of Clinical Trials Leading to FDA Approval” by Denis L. Fontes Jardim, Maria Schwaederle, Caimiao Wei, J. Jack Lee, David S. Hong, Alexander M. Eggermont, Richard L. Schilsky, John Mendelsohn, Vladimir Lazar, Razelle Kurzrock. J Natl Cancer Inst 2015; 107(11): djv253 doi:10.1093/jnci/djv253. The first author’s name should have been listed as Denis L. Jardim. The author regrets the error.
. 2016 Jan 4;108(2):djv423. doi: 10.1093/jnci/djv423
Erratum
Collection date 2016 Feb.
© The Author 2016. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.
PMCID: PMC4857145 PMID: 26727926
This corrects the article "Impact of a Biomarker-Based Strategy on Oncology Drug Development: A Meta-Analysis of Clinical Trials Leading to FDA Approval" in volume 107, djv253.